Stigma, Partners, Providers and Costs: Potential Barriers to PrEP Uptake among US Women
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Pre-Exposure Prophylaxis (PrEP) use has remained low among US women while significantly increasing among men who have sex with men. Besides lack of awareness, women face several social and structural barriers in gaining access to and using PrEP. METHODS: Four focus group discussions with 20 HIV-negative women who live in the Washington DC metropolitan area. RESULTS: The women expressed concerns about social and structural barriers to PrEP use. They were afraid that stigma related to using "HIV medicines" could affect PrEP use as well. They are worried that family and friends may question their reasons for taking anti-retrovirals and suspect that they were HIV-positive. They expected hostile reactions from male partners, including accusations of infidelity and introducing mistrust in their relationships. Communicating with health care providers about sexual matters in general and their need for PrEP in particular were identified as further barriers. Women reported that providers rarely ask about risk behaviors related to HIV acquisition; that short visits hinder establishing a trusting relationship to discuss sensitive matters. They were concerned that disclosure of risk behaviors may result in judgmental responses and harsh treatment from providers. Lastly, women were concerned that PrEP costs, including insurance coverage and copays, would keep PrEP out of their reach. While cognizant of the potential barriers, women were unwavering in their determination to find ways to circumvent challenges to PrEP access. CONCLUSION: Social and structural barriers may impede women's access to PrEP despite their own reported interest. Continued efforts to reduce HIV stigma, improve patient-provider relationships and ensure affordability of PrEP may increase the likelihood that women will use this important prevention modality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.
Grant, R. M., Lama, J. R., Anderson, P. L., McMahan, V., Liu, A. Y., Vargas, L., Goicochea, P., Casapía, M., Guanira-Carranza, J. V., Ramirez-Cardich, M. E., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1011205 · Cited by 5,096 · cited 1×
“PrEP has demonstrated efficacy to prevent HIV transmission in clinical studies worldwide [4,5].”
BackgroundAntiretroviral prophylaxis for HIV prevention in heterosexual men and women.
Baeten, J. M., Donnell, D., Ndase, P., Mugo, N. R., Campbell, J. D., Wangisi, J., Tappero, J. W., Bukusi, E. A., Cohen, C. R., Katabira, E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1108524 · Cited by 3,256 · cited 1×
“PrEP has demonstrated efficacy to prevent HIV transmission in clinical studies worldwide [4,5].”
BackgroundPreexposure Prophylaxis for HIV Infection among African Women
Van Damme, L., Corneli, A., Ahmed, K., Agot, K., Lombaard, J., Kapiga, S., Malahleha, M., Owino, F., Manongi, R., Onyango, J., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202614 · Cited by 1,603 · cited 2×
“This lack of awareness is further complicated by results from the VOICE and FEM-PrEP studies, which failed to demonstrate significant reductions in HIV seroconversion among women [12-14].”
BackgroundResultStigma in the HIV/AIDS epidemic: a review of the literature and recommendations for the way forward
Mahajan, A. P., Sayles, J. N., Patel, V. A., Remien, R. H., Sawires, S. R., Ortiz, D. J., Szekeres, G., & Coates, T. J. (2008) · AIDS · doi:10.1097/01.aids.0000327438.13291.62 · Cited by 1,404 · cited 2×
“, by seeking prophylaxis, a woman may associate herself with HIV and thus face stigma and selfdiscriminate by neglecting to talk to her healthcare provider about her risk behaviors; her family, friends and partner(s) may treat her poorly if she starts taking PrEP and she may become labeled and stereotyped as a woman a…”
Tenofovir-based preexposure prophylaxis for HIV infection among African women.
Marrazzo, J. M., Ramjee, G., Richardson, B. A., Gomez, K., Mgodi, N., Nair, G., Palanee, T., Nakabiito, C., van der Straten, A., Noguchi, L., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1402269 · Cited by 1,296 · cited 1×
“This lack of awareness is further complicated by results from the VOICE and FEM-PrEP studies, which failed to demonstrate significant reductions in HIV seroconversion among women [12-14].”
Vanable, P. A., Carey, M. P., Blair, D. C., & Littlewood, R. A. (2006) · AIDS and Behavior · doi:10.1007/s10461-006-9099-1 · Cited by 619 · cited 1×
“Furthermore, the experience of stigma is associated with internalization of negative social cues among HIV-positive individuals, leading to depression, which is in itself a risk factor of poor adherence to antiretroviral medications [29].”
BackgroundThe Women's Interagency HIV Study: an Observational Cohort Brings Clinical Sciences to the Bench
Bacon, M. C., von Wyl, V., Alden, C., Sharp, G., Robison, E., Hessol, N., Gange, S., Barranday, Y., Holman, S., Weber, K., et al. (2005) · Clinical and Vaccine Immunology · doi:10.1128/cdli.12.9.1013-1019.2005 · Cited by 520 · cited 4×
“Given the importance of these factors as identified by our participants, a similar social integration program may be beneficial for potential PrEP users in the United States.”
BackgroundInfluentialSelf-citationVolk, J. E., Marcus, J. L., Phengrasamy, T., Blechinger, D., Nguyen, D. P., Follansbee, S., & Hare, C. B. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ778 · Cited by 489
Auerbach, J. D., Kinsky, S., Brown, G., & Charles, V. (2015) · AIDS Patient Care and STDs · doi:10.1089/apc.2014.0142 · Cited by 392 · cited 4×
“study found that while HIV-negative women were interested in PrEP, they identified mistrust of medical professionals and social stigma as two of the most important barriers to PrEP uptake [11].”
BackgroundInfluentialPatterson, K. B., Prince, H. A., Kraft, E., Jenkins, A. J., Shaheen, N. J., Rooney, J. F., Cohen, M. S., & Kashuba, A. D. M. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3003174 · Cited by 355 · cited 1×
“On the other hand, further research has highlighted the need for high levels of adherence among women to achieve adequate drug levels in the female genital tract tissue [15] providing additional biologic basis for the lack of efficacy that was reported in the VOICE and Fem-PrEP studies.”
BackgroundSmith, D. K., Grant, R. M., Weidle, P. J., Lansky, A., Mermin, J., & Fenton, K. A. (2011) · PubMed · Cited by 325
Ware, N. C., Wyatt, M. A., Haberer, J. E., Baeten, J. M., Kintu, A., Psaros, C., Safren, S., Tumwesigye, E., Celum, C. L., & Bangsberg, D. R. (2012) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31824a060b · Cited by 255 · cited 3×
“found that social factors such as supportive relationships with family and sexual partners can improve PrEP uptake and adherence [23]; these findings are similar to those of studies on antiretroviral adherence for HIV-positive individuals [24].”
BackgroundResultEisingerich, A. B., Wheelock, A., Gomez, G. B., Garnett, G. P., Dybul, M. R., & Piot, P. K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0028238 · Cited by 242
Smith, D. K., Toledo, L., Smith, D. J., Adams, M. A., & Rothenberg, R. (2012) · AIDS Education and Prevention · doi:10.1521/aeap.2012.24.5.408 · Cited by 196 · cited 1×
“Several studies have identified multiple concerns from potential users of PrEP, including side effects, costs and logistics [10,11,17-19].”
BackgroundSmith, D. K., Thigpen, M. C., Nesheim, S. R., Lampe, M. A., Paxton, L. A., Samandari, T., Lansky, A., Mermin, J., & Fenton, K. A. (2012) · PubMed · Cited by 194
Young, I., & McDaid, L. (2014) · AIDS and Behavior · doi:10.1007/s10461-013-0560-7 · Cited by 187 · cited 2×
“Young and McDaid [20] argued that how individuals “view, chose, and maintain the use of particular HIV prevention methods,” in this case PrEP, are “significantly influenced by social, cultural and structural factors.”
Background(2011) · PubMed · Cited by 175
Corneli, A. L., Deese, J., Wang, M., Taylor, D., Ahmed, K., Agot, K., Lombaard, J., Manongi, R., Kapiga, S., Kashuba, A., et al. (2014) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000158 · Cited by 171 · cited 1×
“This lack of awareness is further complicated by results from the VOICE and FEM-PrEP studies, which failed to demonstrate significant reductions in HIV seroconversion among women [12-14].”
ResultSexual history-taking among primary care physicians.
Wimberly, Y. H., Hogben, M., Moore-Ruffin, J., Moore, S. E., & Fry-Johnson, Y. W. (2006) · PubMed Central · Cited by 167
van der Straten, A., Stadler, J., Luecke, E. H., Laborde, N. D., Hartmann, M., Montgomery, E., & VOICE‐C Study Team (2014) · Journal of the International AIDS Society · doi:10.7448/ias.17.3.19146 · Cited by 128
Montgomery, E., van der Straten, A., Chidanyika, A., Chipato, T., Jaffar, S. S., & PADIAN, N. S. (2010) · AIDS and Behavior · doi:10.1007/s10461-010-9806-9 · Cited by 84 · cited 1×
“Some researchers have identified disclosure and involved partners as important predictors of uptake and adherence to PrEP regimens in Zimbabwe [30].”
BackgroundThe Potential of Pre-Exposure Prophylaxis for Women in Violent Relationships
Braksmajer, A., Senn, T. E., & McMahon, J. M. (2016) · AIDS Patient Care and STDs · doi:10.1089/apc.2016.0098 · Cited by 81
Brief Sexual Histories and Routine HIV/STD Testing by Medical Providers
Lanier, Y., Castellanos, T. J., Barrow, R. Y., Jordan, W. C., CAINE, V. A., & Sutton, M. Y. (2014) · AIDS Patient Care and STDs · doi:10.1089/apc.2013.0328 · Cited by 76 · cited 1×
“[35] collect details on specific exposures allowing for an accurate assessment of HIV risk.”
Loeb, D. F., Lee, R. S., Binswanger, I. A., Ellison, M. C., & Aagaard, E. (2011) · Journal of General Internal Medicine · doi:10.1007/s11606-011-1711-z · Cited by 70 · cited 1×
“Often, providers do not collect comprehensive sexual history [33,34].”
BackgroundNgure, K., Heffron, R. A., Curran, K. G., Vusha, S., Ngutu, M., Mugo, N., Celum, C., & Baeten, J. M. (2016) · AIDS Patient Care and STDs · doi:10.1089/apc.2015.0259 · Cited by 59 · cited 1×
“Additionally, the quality of a clinical encounter is important not just for risk reduction, but also for PrEP initiation: several studies have demonstrated the importance of a healthcare provider's input in PrEP uptake, especially for African American women [37-39].”
Women want Pre-Exposure Prophylaxis but are Advised Against it by Their HIV-positive Counterparts
Goparaju, L., Experton, L. S., Praschan, N. C., Warren-Jeanpiere, L., Young, M. A., & Kassaye, S. (2015) · Journal of AIDS & Clinical Research · doi:10.4172/2155-6113.1000522 · Cited by 58 · cited 2×
“Several studies have identified multiple concerns from potential users of PrEP, including side effects, costs and logistics [10,11,17-19].”
Self-citationRubtsova, A., Wingood, G. M., Dunkle, K., Camp, C. M., & DiClemente, R. J. (2014) · Current HIV Research · doi:10.2174/1570162x12666140129104952 · Cited by 56 · cited 1×
“Additionally, the quality of a clinical encounter is important not just for risk reduction, but also for PrEP initiation: several studies have demonstrated the importance of a healthcare provider’s input in PrEP uptake, especially for African American women [37-39].”
BackgroundJayakumaran, J. S., Aaron, E. Z., Gracely, E., Schriver, E., & Szep, Z. (2016) · PLoS ONE · doi:10.1371/journal.pone.0145670 · Cited by 40 · cited 1×
“Several studies have shown that PrEP awareness is markedly low among women [9-11].”
BackgroundLife Lessons from Women with HIV: Mutuality, Self-Awareness, and Self-Efficacy
Brody, L. R., Jack, D. C., Bruck-Segal, D., Ruffing, E. G., Firpo-Perretti, Y. M., Dale, S. K., Weber, K. M., & Cohen, M. H. (2016) · AIDS Patient Care and STDs · doi:10.1089/apc.2016.0031 · Cited by 35 · cited 1×
“found that social factors such as supportive relationships with family and sexual partners can improve PrEP uptake and adherence [23]; these findings are similar to those of studies on antiretroviral adherence for HIV-positive individuals [24].”
Roberts, E. T., & Matthews, D. D. (2012) · Social Science & Medicine · doi:10.1016/j.socscimed.2012.02.016 · Cited by 35 · cited 1×
“Roberts and Mathews reiterated the importance of structural interventions along with biomedical and behavioral interventions for HIV prevention [21].”
BackgroundPromise and pitfalls of pre-exposure prophylaxis for female sex workers
Cowan, F. M., & Delany‐Moretlwe, S. (2015) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000215 · Cited by 27 · cited 2×
“A study by Cowan and Delaney-Moretlwe focusing on female sex workers, found that structural issues such as stigma from medical professionals, poor social support, and fear of authorities and clients were major barriers to uptake, in addition to risk perception [22].”
BackgroundFinocchario‐Kessler, S., Champassak, S. L., Hoyt, M. J., Short, W. R., Chakraborty, R., Weber, S., Levison, J. E., Phillips, J. B., Storm, D. S., Anderson, J., et al. (2016) · AIDS Patient Care and STDs · doi:10.1089/apc.2015.0268 · Cited by 26 · cited 1×
“In a recent study, fewer than 1 in 5 physicians reported experience with antiretroviral prophylaxis [40].”
BackgroundCounseling to Reduce High-Risk Sexual Behavior in HIV Care: A Multi-Center, Direct Observation Study
Flickinger, T., Berry, S. A., Korthuis, P. T., Saha, S. S., Laws, M. B., Sharp, V., Moore, R. D., & Beach, M. C. (2013) · AIDS Patient Care and STDs · doi:10.1089/apc.2012.0426 · Cited by 23 · cited 1×
“However, as few as half of encounters of HIV-positive individuals involve meaningful counseling about transmission risk [36].”
BackgroundMuessig, K. E., Panter, A. T., Mouw, M. S., Amola, K., Stein, K. E., Murphy, J. S., Maiese, E. M., & Wohl, D. A. (2015) · AIDS Patient Care and STDs · doi:10.1089/apc.2015.0058 · Cited by 19 · cited 4×
“Additionally, the quality of a clinical encounter is important not just for risk reduction, but also for PrEP initiation: several studies have demonstrated the importance of a healthcare provider's input in PrEP uptake, especially for African American women [37-39].”
Influentialvan der Straten, A., Mayo, A., Brown, E. R., Amico, K. R., Cheng, H., Laborde, N. D., Marrazzo, J. M., & Torjesen, K. (2014) · AIDS and Behavior · doi:10.1007/s10461-014-0945-2 · Cited by 11 · cited 1×
“To help address the barriers to adherence, an Adherence Strengthening Program was put in place for participants of the VOICE trial; while it made minimal, if any, differences in adherence, a qualitative review of this program subsequently supported the use of integrative adherence support packages with a special empha…”
Method
Cited by
Velloza, J., Khoza, N., Scorgie, F., Chitukuta, M., Mutero, P., Mutiti, K., Mangxilana, N., Nobula, L., Bulterys, M. A., Atujuna, M., et al. (2020) · Journal of the International AIDS Society · doi:10.1002/jia2.25463 · Cited by 214
Metadata
- Authors
- Goparaju, L., Praschan, N. C., Jeanpiere, L. W., Experton, L. S., Young, M. A., & Kassaye, S.
- Venue
- Journal of AIDS & Clinical Research
- Publisher
- OMICS Publishing Group
- Published
- 2017
- Volume
- 08
- Issue
- 09
- ISSN
- 2155-6113 (ISSN-L)
- OpenAlex
- W2762536000
- Cited by
- 227
- References
- 36
- FWCI
- 9.84
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.